Evidence map›Paper›PMID 27287799›Full record

ArticleDevelopment (Cambridge, England)2016

The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2.

Stefanie Gross, Diana C Garofalo, Dina A Balderes, Teresa L Mastracci, José M Dias, Thomas Perlmann, Johan Ericson, Lori Sussel

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The emerging role of gut hormones.Molecules and cells · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stefanie GrossDepartment of Genetics and Development, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-5259-458X
Diana C GarofaloDepartment of Genetics and Development, Columbia University Medical Center, New York, NY, USA.
Dina A BalderesDepartment of Genetics and Development, Columbia University Medical Center, New York, NY, USA.
Teresa L MastracciDepartment of Genetics and Development, Columbia University Medical Center, New York, NY, USA.
José M DiasDepartment of Cell and Molecular Biology, Karolinska Institute, von Eulers v. 3, 171 77, Stockholm, Sweden.
Thomas PerlmannDepartment of Cell and Molecular Biology, Karolinska Institute, von Eulers v. 3, 171 77, Stockholm, Sweden Ludwig Institute for Cancer Research, Stockholm Branch, Nobels v. 3, 171 77, Stockholm, Sweden.
Johan EricsonDepartment of Cell and Molecular Biology, Karolinska Institute, von Eulers v. 3, 171 77, Stockholm, Sweden.ORCID 0000-0003-0135-3871
Lori SusselDepartment of Genetics and Development, Columbia University Medical Center, New York, NY, USA lori.sussel@ucdenver.edu.ORCID 0000-0003-2832-1319

Funding

Regulation of Pancreatic Islet Cell FateR01DK082590 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2009 to 2026
$7.3M
NIDDK NIH HHS R01 DK082590
6 · The paper itself

Abstract

Intestinal hormone-producing cells represent the largest endocrine system in the body, but remarkably little is known about enteroendocrine cell type specification in the embryo and adult. We analyzed stage- and cell type-specific deletions of Nkx2.2 and its functional domains in order to characterize its role in the development and maintenance of enteroendocrine cell lineages in the mouse duodenum and colon. Although Nkx2.2 regulates enteroendocrine cell specification in the duodenum at all stages examined, it controls the differentiation of progressively fewer enteroendocrine cell populations when deleted from Ngn3(+) progenitor cells or in the adult duodenum. During embryonic development Nkx2.2 regulates all enteroendocrine cell types, except gastrin and preproglucagon. In developing Ngn3(+) enteroendocrine progenitor cells, Nkx2.2 is not required for the specification of neuropeptide Y and vasoactive intestinal polypeptide, indicating that a subset of these cell populations derive from an Nkx2.2-independent lineage. In adult duodenum, Nkx2.2 becomes dispensable for cholecystokinin and secretin production. In all stages and Nkx2.2 mutant conditions, serotonin-producing enterochromaffin cells were the most severely reduced enteroendocrine lineage in the duodenum and colon. We determined that the transcription factor Lmx1a is expressed in enterochromaffin cells and functions downstream of Nkx2.2. Lmx1a-deficient mice have reduced expression of Tph1, the rate-limiting enzyme for serotonin biosynthesis. These data clarify the function of Nkx2.2 in the specification and homeostatic maintenance of enteroendocrine populations, and identify Lmx1a as a novel enterochromaffin cell marker that is also essential for the production of the serotonin biosynthetic enzyme Tph1.

Indexed as

Cell LineageAgingAnimalsBiomarkersColonDuodenumEnterochromaffin CellsEnteroendocrine CellsGene DeletionGene Expression RegulationHomeobox Protein Nkx-2.2Homeodomain ProteinsLIM-Homeodomain ProteinsMice, Inbred C57BLModels, BiologicalMutationBiomarkersHomeobox Protein Nkx-2.2Homeodomain ProteinsLIM-Homeodomain ProteinsLmx1a protein, mousenkx2.2b protein, zebrafishNkx2-2 protein, mouseRNA, MessengerSerotoninTranscription FactorsZebrafish ProteinsEnterochromaffinEnteroendocrine cellsIntestineLmx1aNkx2.2Serotonin

Identifiers

PMID27287799
PMCPMC4958331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.